BioScrip, Option Care merger approved

Friday, August 2, 2019

DENVER – BioScrip stockholders today approved the merger with Option Care. The merger is expected to close on or about Aug. 6. BioScrip and OptionCare announced their merger in March. John Rademacher will be CEO of the combined company and BioScrip President and CEO Dan Greenleaf will be special adviser to the company’s board chairman, Henry Kraemer.